1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Gut	_	_	NN	_	_	_	_	_
2	Microbiota	_	_	NNP	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	RA	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	OA	_	_	NNP	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	hypothesis	_	_	NN	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	not	_	_	RB	_	_	_	_	_
5	only	_	_	RB	_	_	_	_	_
6	oral	_	_	JJ	_	_	_	_	_
7	but	_	_	CC	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	intestinal	_	_	JJ	_	_	_	_	_
10	microbiota	_	_	NN	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	associated	_	_	VBN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	development	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	RA	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	supported	_	_	VBN	_	_	_	_	_
21	by	_	_	IN	_	_	_	_	_
22	many	_	_	JJ	_	_	_	_	_
23	data	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_
25	Zhang	_	_	NNP	_	_	_	_	_
26	et	_	_	FW	_	_	_	_	_
27	al.	_	_	FW	_	_	_	_	_
28	published	_	_	VBD	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	case-control	_	_	JJ	_	_	_	_	_
31	metagenome-wide	_	_	JJ	_	_	_	_	_
32	association	_	_	NN	_	_	_	_	_
33	study	_	_	NN	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_
35	MGWAS	_	_	NNP	_	_	_	_	_
36	)	_	_	-RRB-	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	fecal	_	_	JJ	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	dental	_	_	JJ	_	_	_	_	_
42	and	_	_	CC	_	_	_	_	_
43	salivary	_	_	JJ	_	_	_	_	_
44	microbiomes	_	_	NNS	_	_	_	_	_
45	of	_	_	IN	_	_	_	_	_
46	a	_	_	DT	_	_	_	_	_
47	cohort	_	_	NN	_	_	_	_	_
48	of	_	_	IN	_	_	_	_	_
49	treatment-naive	_	_	JJ	_	_	_	_	_
50	and	_	_	CC	_	_	_	_	_
51	treated	_	_	VBN	_	_	_	_	_
52	RA	_	_	NN	_	_	_	_	_
53	patients	_	_	NNS	_	_	_	_	_
54	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	found	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	RA-associated	_	_	JJ	_	_	_	_	_
6	microbiome	_	_	NN	_	_	_	_	_
7	deviated	_	_	VBD	_	_	_	_	_
8	significantly	_	_	RB	_	_	_	_	_
9	from	_	_	IN	_	_	_	_	_
10	healthy	_	_	JJ	_	_	_	_	_
11	controls	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	all	_	_	DT	_	_	_	_	_
14	sites	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	Haemophilus	_	_	NNP	_	_	_	_	_
6	spp.	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	depleted	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	individuals	_	_	NNS	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	RA	_	_	NNP	_	_	_	_	_
13	at	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	fecal	_	_	JJ	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	oral	_	_	JJ	_	_	_	_	_
18	levels	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	whereas	_	_	IN	_	_	_	_	_
21	Lactobacillus	_	_	NNP	_	_	_	_	_
22	salivarius	_	_	NN	_	_	_	_	_
23	was	_	_	VBD	_	_	_	_	_
24	over-represented	_	_	VBN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	individuals	_	_	NNS	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	RA	_	_	NNP	_	_	_	_	_
29	at	_	_	IN	_	_	_	_	_
30	both	_	_	DT	_	_	_	_	_
31	microbiota	_	_	NN	_	_	_	_	_
32	sites	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Older	_	_	JJR	_	_	_	_	_
2	patients	_	_	NNS	_	_	_	_	_
3	often	_	_	RB	_	_	_	_	_
4	manifest	_	_	VBP	_	_	_	_	_
5	more	_	_	RBR	_	_	_	_	_
6	severe	_	_	JJ	_	_	_	_	_
7	diseases	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	this	_	_	DT	_	_	_	_	_
11	appears	_	_	VBZ	_	_	_	_	_
12	connected	_	_	VBN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	age-related	_	_	JJ	_	_	_	_	_
15	gut	_	_	NN	_	_	_	_	_
16	dysbiosis	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Alterations	_	_	NNS	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	microbiota	_	_	NN	_	_	_	_	_
5	provide	_	_	VBP	_	_	_	_	_
6	plausible	_	_	JJ	_	_	_	_	_
7	candidate	_	_	NN	_	_	_	_	_
8	mechanisms	_	_	NNS	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	driving	_	_	VBG	_	_	_	_	_
11	both	_	_	CC	_	_	_	_	_
12	inflammation	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	altering	_	_	VBG	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	immune	_	_	JJ	_	_	_	_	_
17	response	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	host	_	_	NN	_	_	_	_	_
20	metabolism	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	turn	_	_	NN	_	_	_	_	_
25	may	_	_	MD	_	_	_	_	_
26	modulate	_	_	VB	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	development	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	musculoskeletal	_	_	JJ	_	_	_	_	_
31	problems	_	_	NNS	_	_	_	_	_
32	(	_	_	-LRB-	_	_	_	_	_
33	see	_	_	VB	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	Prevotella	_	_	NNP	_	_	_	_	_
36	copri	_	_	NNP	_	_	_	_	_
37	case	_	_	NN	_	_	_	_	_
38	below	_	_	RB	_	_	_	_	_
39	)	_	_	-RRB-	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	microbiome	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	thus	_	_	RB	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	highly	_	_	RB	_	_	_	_	_
7	plausible	_	_	JJ	_	_	_	_	_
8	target	_	_	NN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	modulation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	diseases	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	aging	_	_	NN	_	_	_	_	_
16	owing	_	_	VBG	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	its	_	_	PRP$	_	_	_	_	_
19	close	_	_	JJ	_	_	_	_	_
20	relationship	_	_	NN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	innate	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	adaptive	_	_	JJ	_	_	_	_	_
25	immune	_	_	JJ	_	_	_	_	_
26	systems	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Components	_	_	NNS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	intestinal	_	_	JJ	_	_	_	_	_
4	microbiota	_	_	NN	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	indeed	_	_	RB	_	_	_	_	_
7	direct	_	_	VB	_	_	_	_	_
8	key	_	_	JJ	_	_	_	_	_
9	aspects	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	host	_	_	NN	_	_	_	_	_
12	immunity	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	particular	_	_	JJ	_	_	_	_	_
16	effector	_	_	NN	_	_	_	_	_
17	T-cell	_	_	NN	_	_	_	_	_
18	differentiation	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	may	_	_	MD	_	_	_	_	_
22	impact	_	_	VB	_	_	_	_	_
23	susceptibility	_	_	NN	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	autoimmune	_	_	JJ	_	_	_	_	_
26	diseases	_	_	NNS	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	RA	_	_	NN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	particular	_	_	JJ	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Different	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	investigating	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	etiology	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	RA	_	_	NNP	_	_	_	_	_
8	have	_	_	VBP	_	_	_	_	_
9	established	_	_	VBN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	involvement	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	regulatory	_	_	JJ	_	_	_	_	_
14	T	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	T-reg	_	_	NNP	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	cells	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	are	_	_	VBP	_	_	_	_	_
22	defective	_	_	JJ	_	_	_	_	_
23	at	_	_	IN	_	_	_	_	_
24	suppressing	_	_	VBG	_	_	_	_	_
25	IFN-γ	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	TNF-α	_	_	NN	_	_	_	_	_
28	production	_	_	NN	_	_	_	_	_
29	by	_	_	IN	_	_	_	_	_
30	conventional	_	_	JJ	_	_	_	_	_
31	T	_	_	NN	_	_	_	_	_
32	cells	_	_	NNS	_	_	_	_	_
33	in	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	peripheral	_	_	JJ	_	_	_	_	_
36	blood	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	active	_	_	JJ	_	_	_	_	_
39	RA	_	_	NN	_	_	_	_	_
40	patients	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	well	_	_	RB	_	_	_	_	_
5	established	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	gut	_	_	NN	_	_	_	_	_
9	microbiota	_	_	NN	_	_	_	_	_
10	–	_	_	:	_	_	_	_	_
11	immune	_	_	JJ	_	_	_	_	_
12	interaction	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	homeostasis	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	via	_	_	IN	_	_	_	_	_
17	balancing	_	_	VBG	_	_	_	_	_
18	pro-	_	_	JJ	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	anti-inflammatory	_	_	JJ	_	_	_	_	_
21	mechanisms	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	can	_	_	MD	_	_	_	_	_
24	regulate	_	_	VB	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	differentiation	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	various	_	_	JJ	_	_	_	_	_
29	T	_	_	NN	_	_	_	_	_
30	cell	_	_	NN	_	_	_	_	_
31	types	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	especially	_	_	RB	_	_	_	_	_
34	T-reg	_	_	NN	_	_	_	_	_
35	cells	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	clear	_	_	JJ	_	_	_	_	_
3	example	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	potential	_	_	JJ	_	_	_	_	_
7	therapeutic	_	_	JJ	_	_	_	_	_
8	effect	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	SCFAs	_	_	NNS	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	short	_	_	JJ	_	_	_	_	_
13	chain	_	_	NN	_	_	_	_	_
14	fatty	_	_	NN	_	_	_	_	_
15	acids	_	_	NNS	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	which	_	_	WDT	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	microbial	_	_	JJ	_	_	_	_	_
21	fermentation	_	_	NN	_	_	_	_	_
22	products	_	_	NNS	_	_	_	_	_
23	found	_	_	VBN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	bowel	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	that	_	_	WDT	_	_	_	_	_
29	have	_	_	VBP	_	_	_	_	_
30	demonstrated	_	_	VBN	_	_	_	_	_
31	a	_	_	DT	_	_	_	_	_
32	profound	_	_	JJ	_	_	_	_	_
33	influence	_	_	NN	_	_	_	_	_
34	on	_	_	IN	_	_	_	_	_
35	T-reg	_	_	NN	_	_	_	_	_
36	cell	_	_	NN	_	_	_	_	_
37	differentiation	_	_	NN	_	_	_	_	_
38	in	_	_	IN	_	_	_	_	_
39	a	_	_	DT	_	_	_	_	_
40	variety	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	experimental	_	_	JJ	_	_	_	_	_
43	models	_	_	NNS	_	_	_	_	_
44	of	_	_	IN	_	_	_	_	_
45	autoimmunity	_	_	NN	_	_	_	_	_
46	or	_	_	CC	_	_	_	_	_
47	inflammatory	_	_	JJ	_	_	_	_	_
48	T-cell-mediated	_	_	JJ	_	_	_	_	_
49	diseases	_	_	NNS	_	_	_	_	_
50	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	elegant	_	_	JJ	_	_	_	_	_
3	collagen-induced	_	_	JJ	_	_	_	_	_
4	arthritis	_	_	NN	_	_	_	_	_
5	mouse	_	_	NN	_	_	_	_	_
6	model	_	_	NN	_	_	_	_	_
7	published	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	Hui	_	_	NNP	_	_	_	_	_
10	et	_	_	FW	_	_	_	_	_
11	al.	_	_	FW	_	_	_	_	_
12	demonstrated	_	_	VBD	_	_	_	_	_
13	that	_	_	IN	_	_	_	_	_
14	butyrate	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	functional	_	_	JJ	_	_	_	_	_
18	SCFA	_	_	NN	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	administration	_	_	NN	_	_	_	_	_
21	inhibited	_	_	VBN	_	_	_	_	_
22	arthritis	_	_	NN	_	_	_	_	_
23	by	_	_	IN	_	_	_	_	_
24	suppressing	_	_	VBG	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	expression	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	inflammatory	_	_	JJ	_	_	_	_	_
29	cytokines	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	authors	_	_	NNS	_	_	_	_	_
3	suggested	_	_	VBD	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	modulation	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	likely	_	_	RB	_	_	_	_	_
8	mediated	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	differentiation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	CD4	_	_	NN	_	_	_	_	_
14	T	_	_	NN	_	_	_	_	_
15	cells	_	_	NNS	_	_	_	_	_
16	towards	_	_	IN	_	_	_	_	_
17	T-reg	_	_	NNP	_	_	_	_	_
18	cells	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	produce	_	_	VBP	_	_	_	_	_
22	anti-inflammatory	_	_	JJ	_	_	_	_	_
23	cytokine	_	_	NN	_	_	_	_	_
24	IL-10	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	thus	_	_	RB	_	_	_	_	_
28	influenced	_	_	VBD	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	function	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	Th17	_	_	NNP	_	_	_	_	_
33	cells	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	mentioned	_	_	VBN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	an	_	_	DT	_	_	_	_	_
5	altered	_	_	VBN	_	_	_	_	_
6	microbiota	_	_	NN	_	_	_	_	_
7	profile	_	_	NN	_	_	_	_	_
8	has	_	_	VBZ	_	_	_	_	_
9	also	_	_	RB	_	_	_	_	_
10	been	_	_	VBN	_	_	_	_	_
11	associated	_	_	VBN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	juvenile	_	_	JJ	_	_	_	_	_
14	idiopathic	_	_	JJ	_	_	_	_	_
15	arthritis	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	JIA	_	_	NNP	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Current	_	_	JJ	_	_	_	_	_
2	evidence	_	_	NN	_	_	_	_	_
3	indeed	_	_	RB	_	_	_	_	_
4	suggests	_	_	VBZ	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	perturbation	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	gut	_	_	NN	_	_	_	_	_
10	microbiota	_	_	NN	_	_	_	_	_
11	may	_	_	MD	_	_	_	_	_
12	contribute	_	_	VB	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	development	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	JIA	_	_	NNP	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	remains	_	_	VBZ	_	_	_	_	_
3	difficult	_	_	JJ	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	however	_	_	RB	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	establish	_	_	VB	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	definitive	_	_	JJ	_	_	_	_	_
11	microbial	_	_	JJ	_	_	_	_	_
12	marker	_	_	NN	_	_	_	_	_
13	or	_	_	CC	_	_	_	_	_
14	specific	_	_	JJ	_	_	_	_	_
15	enterotypes	_	_	NNS	_	_	_	_	_
16	that	_	_	WDT	_	_	_	_	_
17	are	_	_	VBP	_	_	_	_	_
18	associated	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	RA	_	_	NNP	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	hypothesized	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	alteration	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	single	_	_	JJ	_	_	_	_	_
10	bacterial	_	_	JJ	_	_	_	_	_
11	genus	_	_	NN	_	_	_	_	_
12	could	_	_	MD	_	_	_	_	_
13	have	_	_	VB	_	_	_	_	_
14	direct	_	_	JJ	_	_	_	_	_
15	impact	_	_	NN	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	driving	_	_	VBG	_	_	_	_	_
18	inflammation	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	suggested	_	_	VBN	_	_	_	_	_
22	for	_	_	IN	_	_	_	_	_
23	Bacteroides	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	Akkermansia	_	_	NNP	_	_	_	_	_
26	or	_	_	CC	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	anti-inflammatory	_	_	JJ	_	_	_	_	_
29	Faecalobacterium	_	_	NNP	_	_	_	_	_
30	prausnitzii	_	_	NNP	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	which	_	_	WDT	_	_	_	_	_
33	has	_	_	VBZ	_	_	_	_	_
34	been	_	_	VBN	_	_	_	_	_
35	noted	_	_	VBN	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	be	_	_	VB	_	_	_	_	_
38	depleted	_	_	VBN	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	RA	_	_	NNP	_	_	_	_	_
41	patients	_	_	NNS	_	_	_	_	_
42	,	_	_	,	_	_	_	_	_
43	while	_	_	IN	_	_	_	_	_
44	Prevotella	_	_	NNP	_	_	_	_	_
45	and	_	_	CC	_	_	_	_	_
46	Ruminococcus	_	_	NNP	_	_	_	_	_
47	were	_	_	VBD	_	_	_	_	_
48	more	_	_	RBR	_	_	_	_	_
49	prevalent	_	_	JJ	_	_	_	_	_
50	.	_	_	.	_	_	_	_	_


1	Increasing	_	_	VBG	_	_	_	_	_
2	Prevotella	_	_	NNP	_	_	_	_	_
3	copri	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	decreasing	_	_	VBG	_	_	_	_	_
6	Bacteroides	_	_	NNS	_	_	_	_	_
7	concentrations	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	stool	_	_	NN	_	_	_	_	_
11	have	_	_	VBP	_	_	_	_	_
12	both	_	_	DT	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	associated	_	_	VBN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	new	_	_	JJ	_	_	_	_	_
17	onset	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	untreated	_	_	JJ	_	_	_	_	_
20	RA	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	humans	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	above	_	_	JJ	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	although	_	_	IN	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	always	_	_	RB	_	_	_	_	_
8	homogenous	_	_	JJ	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	have	_	_	VBP	_	_	_	_	_
11	directly	_	_	RB	_	_	_	_	_
12	or	_	_	CC	_	_	_	_	_
13	indirectly	_	_	RB	_	_	_	_	_
14	demonstrated	_	_	VBN	_	_	_	_	_
15	that	_	_	IN	_	_	_	_	_
16	genetic	_	_	JJ	_	_	_	_	_
17	risk	_	_	NN	_	_	_	_	_
18	may	_	_	MD	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	modulated	_	_	VBN	_	_	_	_	_
21	by	_	_	IN	_	_	_	_	_
22	alterations	_	_	NNS	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	microbiome	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	that	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	presence	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	particular	_	_	JJ	_	_	_	_	_
32	microbial	_	_	JJ	_	_	_	_	_
33	markers	_	_	NNS	_	_	_	_	_
34	can	_	_	MD	_	_	_	_	_
35	be	_	_	VB	_	_	_	_	_
36	predictive	_	_	JJ	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	disease	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	mentioned	_	_	VBN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	intestinal	_	_	JJ	_	_	_	_	_
5	microbiota	_	_	NN	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	also	_	_	RB	_	_	_	_	_
8	known	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	change	_	_	VB	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	age	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	clinical	_	_	JJ	_	_	_	_	_
5	issues	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	including	_	_	VBG	_	_	_	_	_
8	OA	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	related	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	inflammatory	_	_	JJ	_	_	_	_	_
15	change	_	_	NN	_	_	_	_	_
16	—	_	_	:	_	_	_	_	_
17	either	_	_	CC	_	_	_	_	_
18	specific	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	disease	_	_	NN	_	_	_	_	_
21	or	_	_	CC	_	_	_	_	_
22	associated	_	_	VBN	_	_	_	_	_
23	with	_	_	IN	_	_	_	_	_
24	age	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	OA	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	indeed	_	_	RB	_	_	_	_	_
4	considered	_	_	VBN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	degeneration	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	joint	_	_	JJ	_	_	_	_	_
9	cartilage	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	underlying	_	_	JJ	_	_	_	_	_
13	bone	_	_	NN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	commonly	_	_	RB	_	_	_	_	_
16	occurs	_	_	VBZ	_	_	_	_	_
17	from	_	_	IN	_	_	_	_	_
18	middle	_	_	JJ	_	_	_	_	_
19	age	_	_	NN	_	_	_	_	_
20	onward	_	_	RB	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	precise	_	_	JJ	_	_	_	_	_
3	etiology	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	OA	_	_	NN	_	_	_	_	_
6	remains	_	_	VBZ	_	_	_	_	_
7	unknown	_	_	JJ	_	_	_	_	_
8	thus	_	_	RB	_	_	_	_	_
9	far	_	_	RB	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	even	_	_	RB	_	_	_	_	_
12	if	_	_	IN	_	_	_	_	_
13	various	_	_	JJ	_	_	_	_	_
14	risk	_	_	NN	_	_	_	_	_
15	factors	_	_	NNS	_	_	_	_	_
16	have	_	_	VBP	_	_	_	_	_
17	been	_	_	VBN	_	_	_	_	_
18	associated	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	presence	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	disease	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	including	_	_	VBG	_	_	_	_	_
26	age	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	sex	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	obesity	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	diet	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	local	_	_	JJ	_	_	_	_	_
37	joint	_	_	JJ	_	_	_	_	_
38	injury	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	factors	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	associated	_	_	VBN	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	drastic	_	_	JJ	_	_	_	_	_
9	changes	_	_	NNS	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	intestinal	_	_	JJ	_	_	_	_	_
13	microbiota	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Age	_	_	NN	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	fact	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	shifts	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	intestinal	_	_	JJ	_	_	_	_	_
9	microbiota	_	_	NN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	significant	_	_	JJ	_	_	_	_	_
12	differences	_	_	NNS	_	_	_	_	_
13	between	_	_	IN	_	_	_	_	_
14	younger	_	_	JJR	_	_	_	_	_
15	adults	_	_	NNS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	older	_	_	JJR	_	_	_	_	_
18	people	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	showing	_	_	VBG	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	lower	_	_	JJR	_	_	_	_	_
23	diversity	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	gut	_	_	NN	_	_	_	_	_
26	microbiota	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	greater	_	_	JJR	_	_	_	_	_
30	proportion	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	Bacteroides	_	_	NNS	_	_	_	_	_
33	spp.	_	_	FW	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	a	_	_	DT	_	_	_	_	_
37	distinct	_	_	JJ	_	_	_	_	_
38	abundance	_	_	NN	_	_	_	_	_
39	pattern	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	Clostridium	_	_	NN	_	_	_	_	_
42	groups	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	obesity	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	associated	_	_	VBN	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	phylum-level	_	_	JJ	_	_	_	_	_
9	changes	_	_	NNS	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	microbiota	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	i.	_	_	FW	_	_	_	_	_
15	e.	_	_	FW	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	ratio	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	Firmicutes/Bacteroidetes	_	_	NNP	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	reduced	_	_	VBN	_	_	_	_	_
23	bacterial	_	_	JJ	_	_	_	_	_
24	diversity	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	an	_	_	DT	_	_	_	_	_
28	altered	_	_	VBN	_	_	_	_	_
29	representation	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	bacterial	_	_	JJ	_	_	_	_	_
32	genes	_	_	NNS	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	metabolic	_	_	JJ	_	_	_	_	_
35	pathways	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	diet	_	_	NN	_	_	_	_	_
4	can	_	_	MD	_	_	_	_	_
5	shape	_	_	VB	_	_	_	_	_
6	gut	_	_	NN	_	_	_	_	_
7	microbiota	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	consequently	_	_	RB	_	_	_	_	_
10	change	_	_	VB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	composition	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	metabolism	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	intestinal	_	_	JJ	_	_	_	_	_
17	microbiota	_	_	NN	_	_	_	_	_
18	as	_	_	RB	_	_	_	_	_
19	well	_	_	RB	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	impact	_	_	VB	_	_	_	_	_
22	host	_	_	NN	_	_	_	_	_
23	immune	_	_	JJ	_	_	_	_	_
24	responses	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	reasons	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	OA	_	_	NNP	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	now	_	_	RB	_	_	_	_	_
8	considered	_	_	VBN	_	_	_	_	_
9	an	_	_	DT	_	_	_	_	_
10	induced	_	_	VBN	_	_	_	_	_
11	inflammatory	_	_	JJ	_	_	_	_	_
12	condition	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	role	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	microbiome	_	_	NN	_	_	_	_	_
20	has	_	_	VBZ	_	_	_	_	_
21	emerging	_	_	VBG	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	one	_	_	CD	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	most	_	_	RBS	_	_	_	_	_
27	important	_	_	JJ	_	_	_	_	_
28	factors	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	publications	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	reported	_	_	VBN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	clear	_	_	JJ	_	_	_	_	_
7	demonstration	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	link	_	_	NN	_	_	_	_	_
11	between	_	_	IN	_	_	_	_	_
12	osteoarthritis	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	gut	_	_	NN	_	_	_	_	_
15	microbiota	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	instance	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	animals	_	_	NNS	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	low-grade	_	_	JJ	_	_	_	_	_
8	chronic	_	_	JJ	_	_	_	_	_
9	systemic	_	_	JJ	_	_	_	_	_
10	inflammation	_	_	NN	_	_	_	_	_
11	due	_	_	JJ	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	high-fat	_	_	JJ	_	_	_	_	_
15	diet	_	_	NN	_	_	_	_	_
16	have	_	_	VBP	_	_	_	_	_
17	developed	_	_	VBN	_	_	_	_	_
18	osteoarthritis	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	others	_	_	NNS	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	an	_	_	DT	_	_	_	_	_
24	increased	_	_	VBN	_	_	_	_	_
25	body	_	_	NN	_	_	_	_	_
26	weight	_	_	NN	_	_	_	_	_
27	due	_	_	JJ	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	diet	_	_	NN	_	_	_	_	_
30	have	_	_	VBP	_	_	_	_	_
31	shown	_	_	VBN	_	_	_	_	_
32	an	_	_	DT	_	_	_	_	_
33	increased	_	_	VBN	_	_	_	_	_
34	progression	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	osteoarthritis	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_
38	Metcalfe	_	_	NNP	_	_	_	_	_
39	et	_	_	FW	_	_	_	_	_
40	al.	_	_	FW	_	_	_	_	_
41	proposed	_	_	VBD	_	_	_	_	_
42	that	_	_	IN	_	_	_	_	_
43	metabolic	_	_	JJ	_	_	_	_	_
44	endotoxemia	_	_	NN	_	_	_	_	_
45	(	_	_	-LRB-	_	_	_	_	_
46	raised	_	_	VBN	_	_	_	_	_
47	LPS	_	_	NN	_	_	_	_	_
48	blood	_	_	NN	_	_	_	_	_
49	and	_	_	CC	_	_	_	_	_
50	synovial	_	_	NN	_	_	_	_	_
51	concentrations	_	_	NNS	_	_	_	_	_
52	)	_	_	-RRB-	_	_	_	_	_
53	caused	_	_	VBD	_	_	_	_	_
54	by	_	_	IN	_	_	_	_	_
55	impaired	_	_	VBN	_	_	_	_	_
56	gastric	_	_	JJ	_	_	_	_	_
57	mucosa	_	_	NN	_	_	_	_	_
58	and	_	_	CC	_	_	_	_	_
59	low-grade	_	_	JJ	_	_	_	_	_
60	chronic	_	_	JJ	_	_	_	_	_
61	inflammation	_	_	NN	_	_	_	_	_
62	,	_	_	,	_	_	_	_	_
63	may	_	_	MD	_	_	_	_	_
64	contribute	_	_	VB	_	_	_	_	_
65	to	_	_	TO	_	_	_	_	_
66	the	_	_	DT	_	_	_	_	_
67	onset	_	_	NN	_	_	_	_	_
68	and	_	_	CC	_	_	_	_	_
69	progression	_	_	NN	_	_	_	_	_
70	of	_	_	IN	_	_	_	_	_
71	OA	_	_	NN	_	_	_	_	_
72	in	_	_	IN	_	_	_	_	_
73	obese	_	_	JJ	_	_	_	_	_
74	patients	_	_	NNS	_	_	_	_	_
75	.	_	_	.	_	_	_	_	_

